Fibrocell Science (FCSC) Post Smaller Q2 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Fibrocell Science Reports Third Quarter 2015 Financial Results and Operational Highlights
November 5, 2015 8:03 AM EST- Company to Host Conference Call and Webcast, Today at 8:30 a.m. EST -
EXTON, Pa., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), an autologous cell and gene therapy company focused on developing transformational therapies for rare and serious skin and connective tissue diseases, today reported financial results for the quarter ended September 30, 2015 and recent operational highlights. Fibrocell will host a conference call and webcast today at 8:30 a.m. EST.
The field of gene therapy is rapidly evolving, and we are uniquely... More
